Lung Cancer Considered

By IASLCScience

Lung Cancer Considered episodes

August 04, 2023 IASLC Hot Topic in Basic and Translational Science Meeting Preview
This episode of Lung Cancer Considered previews the upcoming IASLC Hot Topic in Basic and Translational Science Meeting on Resistance to Immunotherapy in NSCLC. Joining host Dr. Stephen Liu are:
Guests:
Dr. Joachim Aerts, Professor of Pulmonary Oncology at Erasmus University Rotterdam and Head of Pulmonary Medicine at Erasmus MC in the Netherlands.
Dr. Kellie Smith, Associate Professor of Oncology at Johns Hopkins University.
Dr. Roberto Ferrara, Medical Oncologist and Immunologist, from Istituto Nazionale dei Tumori di Milano in Milan, Italy.
22 min
August 01, 2023 Updated IASLC - Virtual Tumor Board On SCLC
In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the management of small-cell lung cancer using a virtual tumor board format. SCLC is an aggressive subtype of lung cancer and for patients with advanced, or extensive-stage disease, the current first-line standard of care is chemo-immunotherapy. In the US and in Europe, the approved options are platinum and etoposide with a PDL1 inhibitor: either atezolizumab based on the IMpower 133 trial or durvalumab based on the CASPIAN trial.
50 min
July 18, 2023 iMig Meeting Highlights
In this episode of Lung Cancer Considered, host Dr. Stephen Liu discuss some of the highlights from iMig 2023 – the meeting of the International Mesothelioma Interest Group, an IASLC-endorsed meeting held in late June 2023 in Lille, France.
Guests: Dr. Arnaud Scherpereel, the iMig President and 2023 Conference Chair, currently Professor of Pulmonary and Thoracic Oncology at the University Hospital of Lille.
Dr. Jan van Meerbeeck, Professor of Thoracic Oncology at both Ghent and Antwerp University and Chair of Pulmonology at Antwerp University Hospital. He was also co-Chair of the 2023 iMig meeting
33 min
July 04, 2023 IASLC - EGFR NSCLC In Brazil
This episode of Lung Cancer Considered examines the treatment of EGFR-positive lung cancer in Brazil from early-stage disease to metastatic lung cancer.
Podcast guests:
Dr. Juliana Ominelli, a Brazilian practicing medical oncologist in Rio de Janeiro, Brazil with experience treating EGFR Lung Cancer. She practices at the Brazilian National Cancer Institute –Oncologia DASA.
Dr. Victor Marcondes, thoracic medical oncologist from Rio de Janeiro, Brazil who practices at Oncomed Oncologia and has led several trials in the region focusing on EGFR-positive NSCLC,
38 min
June 20, 2023 Evolving Role of Liquid Biopsy for Lung Cancer
In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion with two global experts about the current and future roles of liquid biopsy and its use for the treatment of lung cancer.
51 min
June 09, 2023 IASLC - ASCO 2023 Highlights
In this episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu lead a discussion on the recently completed ASCO 2023 meeting that included presentation of the new overall survival data from the ADAURA trial as well as the New England Journal of Medicine publication on data from KEYNOTE 671.
58 min
June 06, 2023 WCLC 2023 Preview: Singapore
WCLC 2023 is a global, multi-disciplinary meeting designed for physicians, nurses, clinicians, researchers, scientists, survivors and advocates. This year, the meeting rotates to Singapore and Lung Cancer Considered Hosts Dr. Narjust Florez and Dr. Stephen Liu are joined by the meeting's three co-chairs for a wide-ranging interview about how attendees can make the most out of their experience during IASLC's flagship annual conference.
26 min
May 25, 2023 LCC in Polish: Overcoming Barriers to Lung Cancer Therapy in Poland
LCC in Polish: Overcoming Barriers to Lung Cancer Therapy in Poland
This special Polish-language episode of Lung Cancer Considered focuses on the unique challenges facing clinicians, researchers, and patients in Poland. The podcast also focuses on how physicians help patients overcome barriers to treating lung cancer.
Host: Dr Anna Wrona, Department of Oncology and Radiotherapy, Medical University of Gdansk
Guests:
Professor Rafał Dziadziuszko, M.D., Ph.D., Head, Department of Oncology & Radiotherapy and Early Phase Clinical Trials Centre at the Medical University of Gdańsk
Professor Witold Rzyman, M.D., Ph.D. Head, Department of Thoracic Surgery at the Medical University of Gdańsk
28 min
May 16, 2023 Lung Cancer Considered: Decoding ROS1 Fusions in Lung Cancer
In this episode of Lung Cancer Considered, host Dr. Narjust Florez discusses ROS+1 Fusions in NSCLC, including diagnosis, treatment and new exciting research coming down the pipeline. Her guests are:
Dr. Lorenza Landi, Director of Clinical Trials Unit: Phase 1 and Precision Medicine at the National Cancer Institute Regina Elena in Rome. Dr. Landi has extensive experience and is interested in targeted therapy in lung cancer with a focus on ALK, HER-2/EGFR positive and ROS+1 lung cancer.
Dr. Shirish Gadgeel, Chief of the Division of Hematology and Oncology, at Henry Ford Cancer Institute in Detroit, Mich. Dr. Gadgeel is also part of the Lung Cancer steering committee for the Southwest Oncology Group and he is the Associate Editor of Clinical Lung Cancer and a reviewer for many journals.
41 min
May 15, 2023 Lung Cancer Treatment and Research in Poland (Polish language)
Lung Cancer Treatment and Research in Poland (Polish language) by IASLC
28 min

About Lung Cancer Considered

From the publisher's feed

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.